ロード中...
Ribonuclease-Activated Cancer Prodrug
[Image: see text] Cancer chemotherapeutic agents often have a narrow therapeutic index that challenges the maintenance of a safe and effective dose. Consistent plasma concentrations of a drug can be obtained by using a timed-release prodrug strategy. We reasoned that a ribonucleoside 3′-phosphate co...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American
Chemical Society
2012
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353771/ https://ncbi.nlm.nih.gov/pubmed/22611478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml2002554 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|